All studies
RecruitingTherapeutic exploratory (Phase II)Interventional

I8F-MC-GPIG - Tirzepatide Study of Renal Function in People with Overweight or Obesity and Chronic Kidney Disease with or without Type 2 Diabetes: Focus on Kidney Hypoxia in Relation to Fatty Kidney Disease using Multiparametric Magnetic Resonance Imaging (TREASURE-CKD)

Chronic kidney disease happens when the kidneys slowly lose their ability to filter waste from your blood. Carrying excess weight can cause fat to build up in and around the kidneys, which may reduce oxygen flow and lead to further kidney damage. This study, called TREASURE-CKD, is testing a medicine called tirzepatide. Tirzepatide is already approved to help manage type 2 diabetes and support weight loss. Doctors want to see if it can also treat 'fatty kidney disease' and protect kidney function. Participants will receive either tirzepatide or a dummy injection (placebo) alongside their usual health care. Researchers will use safe, non-invasive MRI scans to check fat levels and oxygen in the kidneys over time. The goal is to find out if this treatment can slow down kidney damage in people with or without type 2 diabetes.

At a glance

Status
Recruiting
Phase
Therapeutic exploratory (Phase II)
Sponsor
Eli Lilly & Co.
Enrolment target
44
Start
02 Jan 2024

What is this study about?

Your kidneys play an essential role in keeping you healthy by filtering waste and extra fluid from your blood. In people who carry excess weight, fat can sometimes gather inside and around the kidneys. Doctors refer to this as fatty kidney disease. Over time, this fat accumulation may restrict blood flow, lower oxygen levels in kidney tissue, and make chronic kidney disease worse.

This clinical trial is exploring whether a medicine called tirzepatide can help. Tirzepatide mimics natural hormones in your body that help control appetite and blood sugar. While it is well known for aiding weight loss and managing diabetes, scientists believe it may also directly relieve stress on the kidneys by reducing harmful kidney fat and boosting tissue oxygen.

During the trial, researchers will use advanced MRI scans to take detailed pictures of the kidneys without using painful procedures. They will also carry out precise tests to see how effectively the kidneys filter blood. The study aims to compare tirzepatide against an inactive dummy medicine (placebo) to see if there is a real, measurable difference in kidney health.

Finding new ways to protect the kidneys is vital. If treatments like tirzepatide can reduce kidney fat and improve function, they could help people with chronic kidney disease avoid severe complications and live longer, healthier lives.

Key takeaways

  • The trial tests if tirzepatide can reduce kidney fat and improve oxygen in the kidneys.
  • It is designed for adults with overweight or obesity and chronic kidney disease.
  • Participants may have type 2 diabetes, but having diabetes is not required.
  • Treatment involves weekly self-injections of either tirzepatide or an inactive placebo.
  • Kidney changes will be checked safely using advanced MRI body scans.
  • Joining is entirely your choice, and you can stop taking part at any time.

Who may be eligible?

You may be able to join this trial if you are aged 18 or older, are living with overweight or obesity, and have been diagnosed with chronic kidney disease. You can take part whether you have type 2 diabetes or not.

You might not be able to join if you have very advanced kidney failure that requires dialysis, or if you have certain other major health conditions that make taking part unsafe. Because the trial uses magnetic resonance imaging (MRI) scanners, people with certain metal implants, pacemakers, or severe claustrophobia may also be excluded.

The research team will review your health history and perform blood and urine tests to make sure the trial is a safe and suitable option for you before you agree to take part.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. I have been told by a doctor that I have chronic kidney disease.
  3. I am currently living with overweight or obesity.
  4. I do not have a pacemaker or metal implants that prevent me from having an MRI scan.
  5. I am comfortable receiving or giving myself a weekly injection under the skin.
Answer every question to see your result.

What does participation involve?

Taking part usually lasts several months and involves regular visits to a specialist clinic. You will be randomly assigned to receive either weekly injections of tirzepatide or a matching placebo injection that contains no active medicine. The study team will teach you how to give these injections under your skin at home. During your clinic visits, you will have health checks, blood and urine tests, and specialized MRI scans of your abdomen to check your kidneys. You may also have a special kidney filtering test using a safe contrast dye called iohexol. Your health will be watched closely by the research team throughout the entire study.

Potential risks and benefits

You may experience health benefits such as weight loss, better blood sugar control, and closer medical attention from kidney specialists, although these benefits cannot be guaranteed. Like all medications, tirzepatide can cause side effects, most commonly mild stomach upsets such as feeling sick, diarrhoea, or constipation, especially when starting treatment. You may also feel brief discomfort during blood tests or find lying still in the MRI scanner noisy or tiring. Taking part is entirely voluntary, and you have the right to withdraw from the trial at any time without giving a reason and without your normal NHS care being affected.

Locations (3)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Denmark
  • —
    Unverified
    Austria
  • —
    Unverified
    Netherlands

Common questions

What is tirzepatide?

Tirzepatide is a medicine that acts like natural gut hormones to help lower blood sugar, reduce appetite, and assist with weight loss.

What is a placebo?

A placebo looks identical to the real medicine but contains no active ingredient. It helps researchers prove whether any health improvements are truly caused by the study drug.

Do I have to have type 2 diabetes to join?

No. The study is open to eligible adults with chronic kidney disease and overweight or obesity, whether they have type 2 diabetes or not.

Does an MRI scan hurt?

No, MRI scans are completely painless. You will simply need to lie still inside a scanner tunnel while the machine takes pictures using harmless magnetic fields.

Can I leave the study if I change my mind?

Yes. You can leave the study at any point. Your decision will never affect the standard medical care you receive from your normal doctors.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "I8F-MC-GPIG - Tirzepatide Study of Renal Function in People …" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.